Sponsor:
Weill Medical College of Cornell University
Code:
NCT03804944
Conditions
Breast Cancer
Eligibility Criteria
Sex: Female
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Focal Radiation therapy
Pembrolizumab (200mg IV for 30 minutes
CDX-301
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-09. This information was provided to ClinicalTrials.gov by Weill Medical College of Cornell University on 2025-02-19.